Metlife Stock Earnings Reports

MetLife reported a strong Q1 2026 driven by broad-based top-line growth, resilient margins and disciplined capital deployment under its New Frontier strategy. Adjusted earnings were $1.6 billion ($2.42/share), up 18% year-over-year, and adjusted EPS rose 23%. Adjusted ROE was 17% (top of the 15%–17% target range). Variable investment income (VII) was strong at $518 million pretax, helped by private equity returns. All operating segments posted year-over-year adjusted earnings growth: Group Benefits (+19%) benefited from favorable working-age mortality and strong sales; Retirement & Income Solutions (+11%) saw VII strength and diversified origination (including PRT and reinsurance); Asia (+31%) and EMEA (+33%) showed robust sales and persistent momentum; Latin America grew sales despite some tax headwinds. MetLife Investment Management (MIM) reported the first fully integrated quarter following the PineBridge acquisition, with modest institutional outflows but a healthy pipeline. Expense discipline produced a direct expense ratio of 11.9% (better than the 12.1% 2026 target). Capital actions included ~$750M in share repurchases, ~$370M of dividends (total ~ $1.1B returned in Q1), an April additional ~$200M repurchase, a 4.4% dividend increase, and a $1B subordinated debt issuance. Liquidity at holding companies was $3.9B (top of $3B–$4B target). Management emphasized diversified, high‑quality private asset exposure, limited risk in stressed areas (no BDC exposure, minimal middle‑market loans), ongoing AI investments, and confidence in delivering the New Frontier commitments.